IDXG Price Targets and Analyst Ratings NASDAQ:IDXG
IDXG Forecast. What You Should Know.
IDXG Historical Ratings and Targets
About Interpace Diagnostics Group
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n... Read more
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.